Screening and utilisation of liquid wastes

Projekt abgeschlossen

The project will develop new treatment methods for liquid waste from the pharmaceutical and fine chemistry industry, in order to contribute to the improvement of water quality and to better utilise the waste for, e.g. denitrification in biological wastewater treatment or for the production of bio-gas.

Land/Region Thema Periode Budget
Wirtschaftswachstum fördern und Arbeitsbedingungen verbessern
Forschung und Entwicklung
15.10.2010 - 31.12.2015
CHF 707'148

Note: the texts under all the headings, with the exception of 'Results achieved', describe the situation before the start of the project.

Hintergrund 1. Reforms for a knowledge-based economy are at the heart of the EU’s Lisbon Agenda. While Hungary has a tradition of academic research, the country intends to improve its innovation profile through the further development of key technologies. Among these are technology industries in the fields that are also the focus of the Swiss Contribution Call for Proposals for R&D: life sciences and biotechnology, medical technology, material science and nanotechnology, environmental technology and technology of energy-saving and renewed alternative energy resources. The Swiss Contribution offers an opportunity for Swiss and Hungarian research institutions to cooperate and build partnerships for mutual benefit.
2. Screening of toxic liquid wastes from the pharmaceutical industry is a requirement for appropriate treatment before discharge into the sewage. To acquire the necessary technology, it is important to allow the industry in Hungary to fulfil legal obligations as well as to reuse and recycle organic matter.


The goal of the project is to contribute to the better use of liquid industrial wastes by developing methods for its treatment and utilisation.

To achieve this, the project will elaborate selection criteria and methods reflecting degradability and biological utilisation. Appropriate wastes can be utilised as external carbon source for denitrification in biological wastewater treatment plants or for biogas production.



Pharmaceutical and fine chemistry companies, Waterworks and sanitation companies, environmental technology enterprises; research community


The project will develop, in a laboratory setting, selection criteria and new methods for the treatment of liquid waste (distillation and membrane operations, oxidation methods, biological treatment techniques, etc.). The process comprises the determination of biological degradability, measurement of volatile content, its removal, the chemical destruction of toxic materials, and the biological treatment and utilisation as substrate for anaerobic biogas production or as external carbon source for denitrification. After pilot scale experiments, the project will scale-up laboratory processes and then transfer results in case studies to the macro-level.


Erreichte Resultate:  

  • 25 different liquid wastes were characterized, treated and utilized in lab scale
  • 3 pharma companies apply screening and treatment methods elaborated by the project
  • All intended experiments successfully completed


Verantwortliche Direktion/Bundesamt DEZA
Kreditbereich Schweizer Beitrag an die erweiterte EU
Projektpartner Vertragspartner
Ausländische staatliche Institution
  • National State Institute North

Budget Laufende Phase Schweizer Beitrag CHF   707'148 Bereits ausgegebenes Schweizer Budget CHF   609'314

Phase 1 15.10.2010 - 31.12.2015   (Completed)